Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |